# A Dose Escalation Study in de Novo Renal Transplantation

> **NCT04311632** · PHASE2 · COMPLETED · sponsor: **ITB-Med LLC** · enrollment: 13 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **BIOLOGICAL:** TCD601
- **DRUG:** Tacrolimus (TAC)
- **DRUG:** Corticosteroids (CS)
- **DRUG:** Mycophenolate Mofetil (MMF)
- **DRUG:** ATG

## Key facts

- **NCT ID:** NCT04311632
- **Lead sponsor:** ITB-Med LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-26
- **Primary completion:** 2023-10-03
- **Final completion:** 2023-10-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311632, "A Dose Escalation Study in de Novo Renal Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04311632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*